Tolbutamide | hsa00010 | Glycolysis / Gluconeogenesis | 8.02E-03 | 2 | P07738, P19367 | BPGM, HK1 | More | |
Tolbutamide | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
Tolbutamide | hsa00061 | Fatty acid biosynthesis | 4.07E-02 | 1 | P33121 | ACSL1 | More | |
Tolbutamide | hsa00071 | Fatty acid degradation | 2.54E-03 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | |
Tolbutamide | hsa00190 | Oxidative phosphorylation | 1.48E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | |
Tolbutamide | hsa00260 | Glycine, serine and threonine metabolism | 2.42E-02 | 1 | P07738 | BPGM | More | |
Tolbutamide | hsa00500 | Starch and sucrose metabolism | 6.17E-07 | 4 | P19367, O43451, P46976, P06737 | HK1, MGAM, GYG1, PYGL | More | |
Tolbutamide | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | |
Tolbutamide | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 1.21E-02 | 1 | P19367 | HK1 | More | |
Tolbutamide | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
Tolbutamide | hsa00590 | Arachidonic acid metabolism | 3.13E-03 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
Tolbutamide | hsa00591 | Linoleic acid metabolism | 1.63E-03 | 1 | P11712 | CYP2C9 | More | |
Tolbutamide | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 3.60E-02 | 1 | Q9H4F1 | ST6GALNAC4 | More | |
Tolbutamide | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.12E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | |
Tolbutamide | hsa00730 | Thiamine metabolism | 8.11E-05 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | |
Tolbutamide | hsa00760 | Nicotinate and nicotinamide metabolism | 3.52E-02 | 1 | P21589 | NT5E | More | |
Tolbutamide | hsa00770 | Pantothenate and CoA biosynthesis | 3.70E-04 | 3 | O95498, O95497, Q9NRN7 | VNN2, VNN1, AASDHPPT | More | |
Tolbutamide | hsa00970 | Aminoacyl-tRNA biosynthesis | 1.16E-07 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | |
Tolbutamide | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Tolbutamide | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
Tolbutamide | hsa01100 | Metabolic pathways | 8.59E-04 | 36 | P05089, O14521, O95455, P21953, P19367, P48426, P32320, Q13370, P11766, P06280, Q16875, O43286, O43451, P07738, P11712, P05186, P24666, P23743, O60701, Q9HCC0, P33121, Q08477, P15907, Q9NY28, Q9UNP4, Q9H4F1, P09960, P37837, P32321, Q9BPW9, Q9UHY7, P43490, Q9Y2B2, P46976, P06737, Q16718 | ARG1, SDHD, TGDS, BCKDHB, HK1, PIP4K2A, CDA, PDE3B, ADH5, GLA, PFKFB3, B4GALT5, MGAM, BPGM, CYP2C9, ALPL, ACP1, DGKA, UGDH, MCCC2, ACSL1, CYP4F3, ST6GAL1, GALNT8, ST3GAL5, ST6GALNAC4, LTA4H, TALDO1, DCTD, DHRS9, ENOPH1, PBEF1, PIGL, GYG1, PYGL, NDUFA5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P05089 | ARG1 | Arginase-1 | 0.807 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.706 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O95455 | TGDS | dTDP-D-glucose 4,6-dehydratase | -0.716 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P21953 | BCKDHB | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | -0.709 | P19367 | HK1 | Hexokinase-1 | P19367 | HK1 | Hexokinase-1 | 1 | P19367 | HK1 | Hexokinase-1 | P48426 | PIP4K2A | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0.713 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P32320 | CDA | Cytidine deaminase | 0.714 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0.728 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | -0.857 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P06280 | GLA | Alpha-galactosidase A | 0.706 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.919 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.779 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O43451 | MGAM | Maltase-glucoamylase | 0.925 | P19367 | HK1 | Hexokinase-1 | P07738 | BPGM | Bisphosphoglycerate mutase | 0.766 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | P11712 | CYP2C9 | Cytochrome P450 2C9 | 0.733 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.883 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | 0.726 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.715 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | P23743 | DGKA | Diacylglycerol kinase alpha | -0.75 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | O60701 | UGDH | UDP-glucose 6-dehydrogenase | 0.725 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.71 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | -0.722 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.74 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q08477 | CYP4F3 | Cytochrome P450 4F3 | 0.793 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | -0.722 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | Q9NY28 | GALNT8 | Probable polypeptide N-acetylgalactosaminyltransferase 8 | 0.817 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.726 | P19367 | HK1 | Hexokinase-1 | Q9H4F1 | ST6GALNAC4 | Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase | 0.711 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | P09960 | LTA4H | Leukotriene A-4 hydrolase | -0.771 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P37837 | TALDO1 | Transaldolase | 0.843 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P32321 | DCTD | Deoxycytidylate deaminase | -0.737 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.899 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.709 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.899 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | Q9Y2B2 | PIGL | N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase | 0.761 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P46976 | GYG1 | Glycogenin-1 | 0.866 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.783 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.794 |
|
Tolbutamide | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
Tolbutamide | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | |
Tolbutamide | hsa03013 | RNA transport | 3.98E-02 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | |
Tolbutamide | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | |
Tolbutamide | hsa03022 | Basal transcription factors | 2.17E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | |
Tolbutamide | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04014 | Ras signaling pathway | 3.65E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04015 | Rap1 signaling pathway | 2.99E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04020 | Calcium signaling pathway | 4.93E-02 | 3 | P17252, P25116, P20020 | PRKCA, F2R, ATP2B1 | More | |
Tolbutamide | hsa04024 | cAMP signaling pathway | 4.93E-02 | 3 | P20020, Q13370, P25116 | ATP2B1, PDE3B, F2R | More | |
Tolbutamide | hsa04060 | Cytokine-cytokine receptor interaction | 4.71E-02 | 2 | P78552, O75509 | IL13RA1, TNFRSF21 | More | |
Tolbutamide | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | |
Tolbutamide | hsa04062 | Chemokine signaling pathway | 2.43E-04 | 14 | P25024, P25025, P09341, P19875, P47992, Q9UBD3, P07948, P42338, P19174, P63218, P50151, P49407, Q08881, P49841 | CXCR1, CXCR2, CXCL1, CXCL2, XCL1, XCL2, LYN, PIK3CB, PLCG1, GNG5, GNG10, ARRB1, ITK, GSK3B | More | |
Tolbutamide | hsa04064 | NF-kappa B signaling pathway | 2.15E-02 | 7 | P14778, P19174, Q04759, P06239, P09341, P19875, Q06643 | IL1R1, PLCG1, PRKCQ, LCK, CXCL1, CXCL2, LTB | More | |
Tolbutamide | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04071 | Sphingolipid signaling pathway | 1.87E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | |
Tolbutamide | hsa04072 | Phospholipase D signaling pathway | 5.10E-04 | 10 | P42338, Q92529, P43657, P25116, P25024, P25025, P19174, P17252, Q14344, P23743 | PIK3CB, SHC3, P2RY5, F2R, CXCR1, CXCR2, PLCG1, PRKCA, GNA13, DGKA | More | |
Tolbutamide | hsa04114 | Oocyte meiosis | 2.99E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04140 | Autophagy - animal | 2.82E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | |
Tolbutamide | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | |
Tolbutamide | hsa04150 | mTOR signaling pathway | 1.06E-02 | 4 | P08069, P42338, Q13322, P49841 | IGF1R, PIK3CB, GRB10, GSK3B | More | |
Tolbutamide | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04211 | Longevity regulating pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04213 | Longevity regulating pathway - multiple species | 1.17E-02 | 5 | P42338, P08069, Q9Y4H2, P11142, Q13547 | PIK3CB, IGF1R, IRS2, HSPA8, HDAC1 | More | |
Tolbutamide | hsa04217 | Necroptosis | 4.42E-04 | 6 | P07900, P15104, P05141, P01584, P0C0S5, Q13557 | HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D | More | |
Tolbutamide | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.29E-02 | 3 | P09493, P17252, P20020 | TPM1, PRKCA, ATP2B1 | More | |
Tolbutamide | hsa04380 | Osteoclast differentiation | 4.80E-02 | 4 | P06239, P42338, P14778, Q8N149 | LCK, PIK3CB, IL1R1, LILRA2 | More | |
Tolbutamide | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
Tolbutamide | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04610 | Complement and coagulation cascades | 1.29E-05 | 2 | P00734, P0C0L4 | F2, C4A | More | |
Tolbutamide | hsa04612 | Antigen processing and presentation | 1.51E-02 | 7 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A | More | |
Tolbutamide | hsa04613 | Neutrophil extracellular trap formation | 6.68E-04 | 17 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q93077, P62807, O60814, P68431, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | |
Tolbutamide | hsa04621 | NOD-like receptor signaling pathway | 1.93E-02 | 8 | Q16539, P10599, Q9H1Y0, P43490, O00463, P01375, P09341, P12838 | MAPK14, TXN, ATG5, PBEF1, TRAF5, TNF, CXCL1, DEFA4 | More | |
Tolbutamide | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | |
Tolbutamide | hsa04650 | Natural killer cell mediated cytotoxicity | 6.78E-07 | 13 | P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | |
Tolbutamide | hsa04657 | IL-17 signaling pathway | 1.19E-04 | 10 | P07900, O00463, Q16539, P49841, P09341, P14780, Q9UJX4, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL1, MMP9, ANAPC5, LCN2, TNF, IL1B | More | |
Tolbutamide | hsa04658 | Th1 and Th2 cell differentiation | 2.21E-04 | 8 | Q04759, P07766, P20963, P19174, P06239, Q9UL17, P14784, Q13761 | PRKCQ, CD3E, CD247, PLCG1, LCK, TBX21, IL2RB, RUNX3 | More | |
Tolbutamide | hsa04659 | Th17 cell differentiation | 1.76E-04 | 8 | Q04759, P19174, P06239, P14784, P14778, Q9UL17, P07766, P20963 | PRKCQ, PLCG1, LCK, IL2RB, IL1R1, TBX21, CD3E, CD247 | More | |
Tolbutamide | hsa04660 | T cell receptor signaling pathway | 2.21E-05 | 14 | P01375, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | |
Tolbutamide | hsa04662 | B cell receptor signaling pathway | 7.25E-03 | 4 | P49841, P42338, P21854, Q8N149 | GSK3B, PIK3CB, CD72, LILRA2 | More | |
Tolbutamide | hsa04714 | Thermogenesis | 1.99E-02 | 3 | P33121, Q16718, O14521 | ACSL1, NDUFA5, SDHD | More | |
Tolbutamide | hsa04726 | Serotonergic synapse | 1.64E-02 | 3 | P17252, P31645, P11712 | PRKCA, SLC6A4, CYP2C9 | More | |
Tolbutamide | hsa04728 | Dopaminergic synapse | 2.82E-02 | 6 | P14416, P63218, P50151, P49841, Q16539, P49407 | DRD2, GNG5, GNG10, GSK3B, MAPK14, ARRB1 | More | |
Tolbutamide | hsa04730 | Long-term depression | 1.55E-03 | 2 | Q14344, P08069 | GNA13, IGF1R | More | |
Tolbutamide | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.26E-04 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | |
Tolbutamide | hsa04913 | Ovarian steroidogenesis | 1.16E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04914 | Progesterone-mediated oocyte maturation | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | |
Tolbutamide | hsa04929 | GnRH secretion | 3.63E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | |
Tolbutamide | hsa04930 | Type II diabetes mellitus | 4.78E-02 | 1 | P19367 | HK1 | More | |
Tolbutamide | hsa04932 | Non-alcoholic fatty liver disease | 9.70E-03 | 4 | P18848, P01584, P13073, O15239 | ATF4, IL1B, COX4I1, NDUFA1 | More | |
Tolbutamide | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.38E-02 | 1 | P48048 | KCNJ1 | More | |
Tolbutamide | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 1.48E-02 | 2 | P20020, P17252 | ATP2B1, PRKCA | More | |
Tolbutamide | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
Tolbutamide | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | |
Tolbutamide | hsa04970 | Salivary secretion | 4.83E-02 | 2 | P20020, P17252 | ATP2B1, PRKCA | More | |
Tolbutamide | hsa04972 | Pancreatic secretion | 1.48E-02 | 2 | P20020, P17252 | ATP2B1, PRKCA | More | |
Tolbutamide | hsa04973 | Carbohydrate digestion and absorption | 5.89E-05 | 3 | O43451, P19367, P42338 | MGAM, HK1, PIK3CB | More | |
Tolbutamide | hsa05012 | Parkinson disease | 2.53E-02 | 5 | O15239, P13073, P05141, P18848, Q13557 | NDUFA1, COX4I1, SLC25A5, ATF4, CAMK2D | More | |
Tolbutamide | hsa05016 | Huntington disease | 2.29E-03 | 9 | O15239, Q16718, O14521, P13073, P30876, P62487, P05141, O00268, Q13561 | NDUFA1, NDUFA5, SDHD, COX4I1, POLR2B, POLR2G, SLC25A5, TAF4, DCTN2 | More | |
Tolbutamide | hsa05020 | Prion disease | 3.37E-03 | 7 | P13591, P01584, P11142, O15239, P13073, P18848, P05141 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5 | More | |
Tolbutamide | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.89E-03 | 11 | O15239, Q16718, O14521, P13073, P18848, Q13561, P05141, P17252, P01584, Q08752, Q13557 | NDUFA1, NDUFA5, SDHD, COX4I1, ATF4, DCTN2, SLC25A5, PRKCA, IL1B, PPID, CAMK2D | More | |
Tolbutamide | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Tolbutamide | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.70E-05 | 7 | Q16539, P09341, P19875, P19174, P25024, P25025, P07948 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | |
Tolbutamide | hsa05133 | Pertussis | 2.64E-03 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | |
Tolbutamide | hsa05134 | Legionellosis | 6.38E-04 | 6 | P01584, P11215, P68104, P11142, P09341, P19875 | IL1B, ITGAM, EEF1A1, HSPA8, CXCL1, CXCL2 | More | |
Tolbutamide | hsa05135 | Yersinia infection | 4.65E-02 | 5 | P13612, P06239, Q16539, P01375, P49841 | ITGA4, LCK, MAPK14, TNF, GSK3B | More | |
Tolbutamide | hsa05140 | Leishmaniasis | 2.47E-02 | 5 | P13612, O75015, P01375, P49006, Q16539 | ITGA4, FCGR3B, TNF, MARCKSL1, MAPK14 | More | |
Tolbutamide | hsa05143 | African trypanosomiasis | 1.93E-04 | 2 | P69905, P68871 | HBA2, HBB | More | |
Tolbutamide | hsa05144 | Malaria | 2.23E-04 | 7 | P60033, P69905, P68871, O60603, P01375, P35443, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | |
Tolbutamide | hsa05146 | Amoebiasis | 5.06E-05 | 9 | P09341, P19875, P14778, P27930, P01375, P42338, P11215, P05089, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, PIK3CB, ITGAM, ARG1, ACTN1 | More | |
Tolbutamide | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | |
Tolbutamide | hsa05163 | Human cytomegalovirus infection | 1.69E-03 | 8 | P01375, P63218, P50151, P49841, P14778, P25025, Q16539, O00463 | TNF, GNG5, GNG10, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | |
Tolbutamide | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | |
Tolbutamide | hsa05202 | Transcriptional misregulation in cancer | 8.39E-04 | 13 | Q15532, P41732, P14780, P27930, P14923, Q16548, Q13077, O15550, P08069, P35226, P05164, P08246, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, TRAF1, UTX, IGF1R, BMI1, MPO, ELA2, GADD45A | More | |
Tolbutamide | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | |
Tolbutamide | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Tolbutamide | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa05214 | Glioma | 9.95E-03 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa05216 | Thyroid cancer | 3.60E-02 | 1 | Q13772 | NCOA4 | More | |
Tolbutamide | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa05224 | Breast cancer | 1.49E-02 | 1 | P08069 | IGF1R | More | |
Tolbutamide | hsa05225 | Hepatocellular carcinoma | 6.30E-04 | 3 | Q92529, P08069, P51531 | SHC3, IGF1R, SMARCA2 | More | |
Tolbutamide | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | |
Tolbutamide | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Tolbutamide | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
Tolbutamide | hsa05415 | Diabetic cardiomyopathy | 2.47E-03 | 7 | P17252, P05141, O15239, Q16718, O14521, P13073, Q13557 | PRKCA, SLC25A5, NDUFA1, NDUFA5, SDHD, COX4I1, CAMK2D | More | |
Tolbutamide | hsa05418 | Fluid shear stress and atherosclerosis | 2.87E-04 | 7 | Q16539, P42338, P10599, P14780, P01375, P14778, P27930 | MAPK14, PIK3CB, TXN, MMP9, TNF, IL1R1, IL1R2 | More | |